Fitch affirms Nebraska Medicine’s ‘AA-‘ rating

Fitch Ratings affirmed its “AA-” rating on Omaha-based Nebraska Medicine’s outstanding bonds. Concurrently, Fitch assigned its “AA-” issuer default rating to the academic healthcare provider.

Advertisement

The affirmation and assignment are based on several factors, including Nebraska Medicine’s unique position as the only public academic medical center in the state, strong operating margins and light debt burden.

The outlook is stable.

More articles on healthcare finance:
For-profit hospital operators by the numbers: A look at HCA, Tenet, CHS, LifePoint and UHS
HCA’s profit jumps 25% to $820M in Q2
CHS sees net loss narrow to $110M, pursues $2B hospital divestiture plan

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.